The Latest Breaking News from Johnson & Johnson (

The healthcare sector is proving to be a robust investment haven, particularly as it continues to evolve with groundbreaking technology and strong government support. Therefore, adding strong A-rated stocks like Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK) could help garner significant returns. Read more….

‘I used to walk everywhere, but now I just potter around the house. I no longer walk to the shops,’ June Dunne tells Maya Oppenheim

Dividend King J&J can boost its MedTech business with Nvidia’s help.

 The amount of the financial settlement has not been made public, although it is expected millions have been paid out

This dividend aristocrat crushed Q2 earnings and issued strong guidance, and still has some fuel left in the tank for more growth.

Women claimed the implants caused infection, bleeding, chronic pain, bladder and bowel perforations, and problems urinating

Settlement from first successful group claim in England expected to total millions of pounds, but size of payments unknown

Big Pharma exploited patent laws to stifle competition amid Medicare price negotiations, according to a new report

Avon Products Inc. is declaring bankruptcy in the face of numerous lawsuits claiming that the talcum powder in its products causes cancer.

The healthcare sector is poised for significant growth, driven by advancements in drug development, ongoing research and development (R&D) efforts, and its ability to remain resilient even during economic downturns. Thus, investors might consider buying bargain pharma stocks: Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) for…

These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income.